Stockreport

Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders [Yahoo! Finance]

ONO PHARM CO UNSP/ADR  (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
PDF SAN DIEGO, March 03, 2026 BUSINESS WIRE Sinopia Biosciences, Inc. , a biotechnology company advancing novel therapeutics discovered using its proprietary LEADS® (LEarn [Read more]